Search Results - "Cavallari, Joseph F"

Refine Results
  1. 1

    The efflux inhibitor phenylalanine-arginine beta-naphthylamide (PAβN) permeabilizes the outer membrane of gram-negative bacteria by Lamers, Ryan P, Cavallari, Joseph F, Burrows, Lori L

    Published in PloS one (27-03-2013)
    “…Active efflux of antimicrobial agents is a primary mechanism by which bacterial pathogens can become multidrug resistant. The combined use of efflux pump…”
    Get full text
    Journal Article
  2. 2

    Metabolic endotoxemia is dictated by the type of lipopolysaccharide by Anhê, Fernando F., Barra, Nicole G., Cavallari, Joseph F., Henriksbo, Brandyn D., Schertzer, Jonathan D.

    Published in Cell reports (Cambridge) (14-09-2021)
    “…Lipopolysaccharides (LPSs) can promote metabolic endotoxemia, which is considered inflammatory and metabolically detrimental based on Toll-like receptor (TLR)4…”
    Get full text
    Journal Article
  3. 3
  4. 4

    RIPK2 Dictates Insulin Responses to Tyrosine Kinase Inhibitors in Obese Male Mice by Duggan, Brittany M, Cavallari, Joseph F, Foley, Kevin P, Barra, Nicole G, Schertzer, Jonathan D

    Published in Endocrinology (Philadelphia) (01-08-2020)
    “…Abstract Tyrosine kinase inhibitors (TKIs) used in cancer are also being investigated in diabetes. TKIs can improve blood glucose control in diabetic cancer…”
    Get full text
    Journal Article
  5. 5

    Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance by Henriksbo, Brandyn D, Lau, Trevor C, Cavallari, Joseph F, Denou, Emmanuel, Chi, Wendy, Lally, James S, Crane, Justin D, Duggan, Brittany M, Foley, Kevin P, Fullerton, Morgan D, Tarnopolsky, Mark A, Steinberg, Gregory R, Schertzer, Jonathan D

    Published in Diabetes (New York, N.Y.) (01-11-2014)
    “…Statins reduce lipid levels and are widely prescribed. Statins have been associated with an increased incidence of type 2 diabetes, but the mechanisms are…”
    Get full text
    Journal Article
  6. 6

    Bacterial peptidoglycan stimulates adipocyte lipolysis via NOD1 by Chi, Wendy, Dao, Dyda, Lau, Trevor C, Henriksbo, Brandyn D, Cavallari, Joseph F, Foley, Kevin P, Schertzer, Jonathan D

    Published in PloS one (14-05-2014)
    “…Obesity is associated with inflammation that can drive metabolic defects such as hyperlipidemia and insulin resistance. Specific metabolites can contribute to…”
    Get full text
    Journal Article
  7. 7

    Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia by Duggan, Brittany M., Foley, Kevin P., Henriksbo, Brandyn D., Cavallari, Joseph F., Tamrakar, Akhilesh K., Schertzer, Jonathan D.

    Published in Scientific reports (08-05-2017)
    “…Inflammation underpins aspects of insulin resistance and dysglycemia. Microbiota-derived cell wall components such as muropeptides or endotoxin can trigger…”
    Get full text
    Journal Article
  8. 8

    Changes to Its Peptidoglycan-Remodeling Enzyme Repertoire Modulate β-Lactam Resistance in Pseudomonas aeruginosa by CAVALLARI, Joseph F, LAMERS, Ryan P, SCHEURWATER, Edie M, MATOS, Andrea L, BURROWS, Lori L

    Published in Antimicrobial Agents and Chemotherapy (01-07-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  9. 9

    Gut microbiota impairs insulin clearance in obese mice by Foley, Kevin P., Zlitni, Soumaya, Duggan, Brittany M., Barra, Nicole G., Anhê, Fernando F., Cavallari, Joseph F., Henriksbo, Brandyn D., Chen, Cassandra Y., Huang, Michael, Lau, Trevor C., Plante, Roxanne, Schwab, Michael, Marette, André, Schertzer, Jonathan D.

    Published in Molecular metabolism (Germany) (01-12-2020)
    “…Hyperinsulinemia can be both a cause and consequence of obesity and insulin resistance. Hyperinsulinemia can result from increased insulin secretion and/or…”
    Get full text
    Journal Article
  10. 10

    Intestinal Microbiota Contributes to Energy Balance, Metabolic Inflammation, and Insulin Resistance in Obesity by Cavallari, Joseph F, Schertzer, Jonathan D

    Published in Journal of Obesity & Metabolic Syndrome (01-09-2017)
    “…Obesity is associated with increased risk of developing metabolic diseases such as type 2 diabetes. The origins of obesity are multi-factorial, but ultimately…”
    Get full text
    Journal Article
  11. 11

    Micronutrients impact the gut microbiota and blood glucose by Barra, Nicole G, Anhê, Fernando F, Cavallari, Joseph F, Singh, Anita M, Chan, Darryl Y, Schertzer, Jonathan D

    Published in Journal of endocrinology (01-08-2021)
    “…Micronutrients influence hormone action and host metabolism. Dietary minerals, trace elements, and vitamins can alter blood glucose and cellular glucose…”
    Get full text
    Journal Article
  12. 12

    Statins Promote Interleukin-1β-Dependent Adipocyte Insulin Resistance Through Lower Prenylation, Not Cholesterol by Henriksbo, Brandyn D, Tamrakar, Akhilesh K, Xu, Joshua, Duggan, Brittany M, Cavallari, Joseph F, Phulka, Jobanjit, Stampfli, Martin R, Ashkar, Ali A, Schertzer, Jonathan D

    Published in Diabetes (New York, N.Y.) (01-07-2019)
    “…Statins lower cholesterol and adverse cardiovascular outcomes, but this drug class increases diabetes risk. Statins are generally anti-inflammatory. However,…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Different Th17 immunity in gut, liver, and adipose tissues during obesity: the role of diet, genetics, and microbes by Cavallari, Joseph F., Denou, Emmanuel, Foley, Kevin P., Khan, Waliul I., Schertzer, Jonathan D.

    Published in Gut microbes (02-01-2016)
    “…Microbes modify immunometabolism responses linking obesity and type 2 diabetes. Immunity helps maintain a host-microbe symbiosis, but inflammation can promote…”
    Get full text
    Journal Article
  15. 15

    2017-P: Gut Microbes after Bariatric Surgery in Humans Improve Glucose Control in Mice without Fat Loss by ANHÊ, FERNANDO FORATO, FOLEY, KEVIN P., BARRA, NICOLE G., DUGGAN, BRITTANY M., CAVALLARI, JOSEPH F., HENRIKSBO, BRANDYN D., CANI, PATRICE D., BIERTHO, LAURENT, TCHERNOF, ANDRE, MARETTE, ANDRE, SCHERTZER, JONATHAN D.

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Bariatric surgery (BS) is the most efficacious treatment against severe obesity and T2D. Among bariatric procedures, biliopancreatic diversion with duodenal…”
    Get full text
    Journal Article
  16. 16

    2036-P: Gut Microbes Regulate Insulin Clearance in Mice by FOLEY, KEVIN P., ZLITNI, SOUMAYA, DUGGAN, BRITTANY M., HENRIKSBO, BRANDYN D., BARRA, NICOLE G., CAVALLARI, JOSEPH F., ANHÊ, FERNANDO FORATO, LAU, TREVOR, CHEN, YUK KWAN, SCHERTZER, JONATHAN D.

    Published in Diabetes (New York, N.Y.) (01-06-2019)
    “…Obesity and insulin resistance are associated with hyperinsulinemia, which is caused by increased insulin secretion and/or reduced insulin clearance. Impaired…”
    Get full text
    Journal Article
  17. 17

    Targeting macrophage scavenger receptor 1 promotes insulin resistance in obese male mice by Cavallari, Joseph F., Anhê, Fernando F., Foley, Kevin P., Denou, Emmanuel, Chan, Rebecca W., Bowdish, Dawn M. E., Schertzer, Jonathan D.

    Published in Physiological reports (01-11-2018)
    “…Immune components can bridge inflammatory triggers to metabolic dysfunction. Scavenger receptors sense lipoproteins, but it is not clear how different…”
    Get full text
    Journal Article
  18. 18
  19. 19

    22: NOD2 immunity protects against obesity-induced inflammation and insulin resistance by Cavallari, Joseph F., Fullerton, Morgan D., Denou, Emmanuel, Foley, Kevin P., Henriksbo, Brandyn D., Lau, Trevor C., Schertzer, Jonathan D.

    Published in Cytokine (Philadelphia, Pa.) (01-11-2014)
    “…Obesity is associated with immune cell infiltration and inflammation in metabolic tissues that contributes to insulin resistance. Pattern recognition receptors…”
    Get full text
    Journal Article
  20. 20

    The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PA beta N) Permeabilizes the Outer Membrane of Gram-Negative Bacteria. e60666 by Lamers, Ryan P, Cavallari, Joseph F, Burrows, Lori L

    Published in PloS one (01-03-2013)
    “…Active efflux of antimicrobial agents is a primary mechanism by which bacterial pathogens can become multidrug resistant. The combined use of efflux pump…”
    Get full text
    Journal Article